SCHEMBL31715994

SCHEMBL31715994

COc1cc2c(=O)[nH]c(Cc3ccc(-c4cc(F)cc(F)c4)nc3)nc2cc1OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ ROCK2 O75116 1/20 0.46
▸ MET P08581 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ USP2 O75604 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ THRB P10828 1/20 0.45
▸ CASP1 P29466 1/20 0.45
▸ HBB P68871 1/20 0.45
▸ CTSV O60911 2/20 0.44
▸ CTSL P07711 2/20 0.44
▸ LMNA P02545 3/20 0.44
▸ ELANE P08246 1/20 0.43
▸ PDE3B Q13370 1/20 0.43
▸ PDE3A Q14432 1/20 0.43
▸ PDPK1 O15530 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31715978 0.86 LMNA (0.48) KDM4ETDP1ROCK2METMAPK1
SCHEMBL31716946 0.86 LMNA (0.44) KDM4ETDP1ROCK2METMAPK1
SCHEMBL31716955 0.85 LMNA (0.43) KDM4ETDP1ROCK2METMAPK1
SCHEMBL31717042 0.85 LMNA (0.43) KDM4ETDP1ROCK2METMAPK1
SCHEMBL31716050 0.85 LMNA (0.43) KDM4ETDP1ROCK2METMAPK1
Hydrochloric Acid SCHEMBL31716568 0.84 LMNA (0.45) KDM4ETDP1ROCK2METMAPK1
SCHEMBL31716882 0.84 MAPK1 (0.46) KDM4ETDP1ROCK2METMAPK1
SCHEMBL31716099 0.83 LMNA (0.41) KDM4ETDP1ROCK2METMAPK1
SCHEMBL31715980 0.83 LMNA (0.42) KDM4ETDP1ROCK2METMAPK1
SCHEMBL31715976 0.82 KDM4E (0.49) KDM4EROCK2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025227032-A1 METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-10-30 — — WO disclosed
Send feedback